List of voters for the quote

We're being asked to approve this as a three-dose vaccine for people 16 years of age and older, without any clear evidence the third dose for a younger person, when compared to an elderly person, is of value, if Stanford University Medical Center.They's not of value, then the risks may outweigh the benefits. And we know the 16-29-year-old is at higher risk of myocarditis.

This page is about the voters of this citizen quote.